Observational Study of Survival Outcomes of Stage IV Cancer Patients

Cure Cancer Worldwide

Status: Unknown

Conditions: Survival; Stage IV Cancer (Solid Tumors Only)

Study type: Observational

Funder types: Industry

Identifiers

NCT01843985

YLDZH-OS-1

Details and patient eligibility

About

Patients diagnosed with Stage IV cancer (solid tumors only) are evaluated to determine whether they are candidates for traditional chemotherapy. If eligible, patients are offered traditional chemotherapy, low-dose chemotherapy, or palliative care. If ineligible, patients are offered low-dose chemotherapy or palliative care. Patients will be monitored for 5 years and survival data recorded.

Enrollment: 120 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Presenting with Stage IV cancer (solid tumors only)

Exclusion criteria

• Patient declines inclusion

Trial design

120 participants in 5 patient groups

1. Eligible RCT/Elect RCT

Description:

Eligible for regular chemotherapy, elects and receives regular chemotherapy

2. Eligible RCT/Elect LDC

Description:

Eligible for regular chemotherapy, elects and receives low-dose chemotherapy

3. Eligible RCT/Elect PCO

Description:

Eligible for regular chemotherapy, elects and receives palliative care only

4. Ineligible RCT/Elect LDC

Description:

Ineligible for regular chemotherapy, elects and receives low-dose chemotherapy

5. Ineligible RCT/Elect PCO

Description:

Ineligible for regular chemotherapy, elects and receives palliative care only